Quarterly Transactions Made in Apellis Pharmaceuticals, Inc. (APLS)
This table provides information about the institutional ownership of Apellis Pharmaceuticals, Inc. (APLS). The information is specifically focused on institutions that hold shares of Apellis Pharmaceuticals, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 13,098,976 | 5,732,037 | 18,831,013 | 4,641,772 | 7,307,116 | 11,948,888 | 6,882,125 | |
| Q4 2021 | 12,120,944 | 9,126,572 | 21,247,516 | 5,400,797 | 3,383,931 | 8,784,728 | 12,462,788 | |
| Q1 2022 | 13,223,789 | 3,935,145 | 17,158,934 | 6,082,248 | 2,230,351 | 8,312,599 | 8,846,335 | |
| Q2 2022 | 8,147,211 | 1,934,270 | 10,081,481 | 6,891,283 | 1,144,265 | 8,035,548 | 2,045,933 | |
| Q3 2022 | 6,419,029 | 12,848,913 | 19,267,942 | 11,350,224 | 0 | 11,350,224 | 7,917,718 | |
| Q4 2022 | 10,897,814 | 5,280,281 | 16,178,095 | 7,257,282 | 0 | 7,257,282 | 8,920,813 | |
| Q1 2023 | 11,068,381 | 7,053,566 | 18,121,947 | 6,303,084 | 40,000 | 6,343,084 | 11,778,863 | |
| Q2 2023 | 10,284,026 | 2,762,634 | 13,046,660 | 15,863,747 | 945,880 | 16,809,627 | -3,762,967 | |
| Q3 2023 | 27,117,280 | 6,766,386 | 33,883,666 | 14,680,818 | 978,077 | 15,658,895 | 18,224,771 | |
| Q4 2023 | 9,307,886 | 19,333,533 | 28,641,419 | 7,139,326 | 0 | 7,139,326 | 21,502,093 | |
| Q1 2024 | 6,591,518 | 18,876,823 | 25,468,341 | 11,064,149 | 0 | 11,064,149 | 14,404,192 | |
| Q2 2024 | 13,033,040 | 3,608,967 | 16,642,007 | 8,154,878 | 0 | 8,154,878 | 8,487,129 | |
| Q3 2024 | 11,181,144 | 3,533,986 | 14,715,130 | 8,089,024 | 1 | 8,089,025 | 6,626,105 | |